Doximity (DOCS) vs Synopsys (SNPS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Synopsys (SNPS) has outperformed Doximity (DOCS) over the past year, gaining 5.2% versus a loss of 61.2%. Over five years, SNPS leads with a +64.1% price change compared with -60.4% for DOCS. Synopsys is the larger company by market cap ($95.39 billion vs $5.24 billion), about 18.2 times the size.
On valuation, Doximity trades at a lower forward P/E (18.9x vs 26.8x for Synopsys). Doximity converts more of its revenue into profit, with a net margin of 30.4% versus 18.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DOCS | SNPS |
|---|---|---|
| Share price | $29.38 | $497.75 |
| Market cap | $5.24B | $95.39B |
| 1-day change | +6.10% | -0.98% |
| YTD return | -37.47% | +7.01% |
| 1-year return | -61.21% | +5.20% |
| 5-year return | -60.37% | +64.13% |
| P/E ratio (TTM) | 34.56 | 87.94 |
| Forward P/E | 18.87 | 26.79 |
| EPS (TTM) | $0.85 | $5.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $644.86M | $7.05B |
| Revenue growth (YoY) | +13.05% | +15.12% |
| Net income (latest FY) | $196.05M | $1.33B |
| Gross margin | 89.09% | 76.98% |
| Operating margin | 33.33% | 12.97% |
| Net margin | 30.40% | 18.89% |
| 52-week high | $73.53 | $539.48 |
| 52-week low | $17.15 | $362.55 |
| Distance from 52-week high | -60.04% | -7.74% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +0.99% | +14.63% |
| Average volume | 4.39M | 2.02M |
| Shares outstanding | 127.35M | 191.64M |
| Employees | 880 | 28,000 |
| Sector | Technology | Technology |
| Industry | EDP Services | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Synopsys is about 18.2 times larger than Doximity by market value ($95.39B vs $5.24B).
- SNPS has outperformed DOCS by 66.4 percentage points over the past year.
- Synopsys trades at a higher earnings multiple (87.9x vs 34.6x trailing P/E).
- Doximity is more profitable, keeping 30.4 cents of every revenue dollar as net income versus 18.9 cents for Synopsys.
About Doximity
DOCS stock →Doximity, Inc. operates a digital platform for medical professionals in the United States.
Technology · EDP Services · 880 employees
About Synopsys
SNPS stock →Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries.
Technology · Computer Software: Prepackaged Software · 28,000 employees
DOCS vs SNPS FAQ
Which is bigger, Doximity or Synopsys?
Synopsys (SNPS) is larger, with a market capitalization of $95.39B compared with $5.24B for Doximity (DOCS).
Which stock has performed better over the past year, DOCS or SNPS?
SNPS returned +5.20% over the past 12 months, compared with -61.21% for DOCS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DOCS or SNPS?
DOCS has the lower trailing P/E at 34.6, versus 87.9 for SNPS. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Doximity and Synopsys in the same industry?
Both are in the Technology sector, but in different industries: EDP Services for Doximity and Computer Software: Prepackaged Software for Synopsys.